Zacks Prepared Foods Pitch Adds No New Evidence; AVO Remains a WAIT

What happened

Zacks published a piece exploring whether prepared foods from the Calavo acquisition can become a new growth engine for Mission Produce, highlighting guacamole, sourcing strength, and efficiency as focal points. The article repeats the bull case of the merger but lacks depth on execution risks already detailed in filings and our internal analysis. Our latest DeepValue master report rates AVO a WAIT at $13.17, with attractive entry at $11 and trim above $16, embedding low-to-mid single-digit volume growth and stable margins. The key risks to the prepared foods thesis are integration complexity, tariff impacts, and the need to realize $25M in annual synergies within 18 months post-close. Without concrete regulatory approvals and synergy delivery, the prepared foods upside remains speculative and does not alter our valuation.

Implication

Near-term, the stock is at $13.17, within our WAIT range, and the new Zacks article adds no new information beyond what is already in our model. Upside to our bull case of $18 depends on prompt Calavo closure and at least $25M synergy run-rate, which is uncertain given regulatory and integration hurdles. Downside to $10 persists if trade frictions and execution missteps compress margins, a risk that the promotional article ignores. We would only turn constructive on a pullback towards $11 (≈6.5-7x EBITDA) or on clear evidence of merger approvals and synergy capture. Current holders should trim if the stock approaches $16, while new capital should wait for better entry or concrete catalysts.

Thesis delta

No change to our WAIT thesis. The Zacks article merely reiterates the prepared foods opportunity already embedded in our base and bull scenarios. We require visible Calavo approvals and synergy delivery before increasing conviction or adjusting valuation.